2024
Escitalopram receives approval in Japan
Selected as one of the 1,000+ global powerhouses
Ibandronate receives approval in Japan
2022
2020
Selected as a global powerhouse
Selected as Jeju local small and
medium-sized enterprise
2018
2017
Establishment of BRIO PHARMA,
a Japanese corporation
Selected for the high-growth company export capacity enhancement project
Awarded Export Award at the 6th Jeju
Exporter's Day
2016
2014
Moved into new office building
(Hawon-dong) in Seogwipo-si, Jeju-do
Headquarters moved to Seogwipo-si,
Jeju-do (Beophwan-dong)
2013
2011
Awarded the $20 million Export Tower Award at the 48th Trade Day
Received the $10 million Export Tower Award at the 47th Trade Day
2010
2009
OHSONG PHARM Co., Ltd. established